Patents
Patents for C07C 275 - Derivatives of urea, i.e. compounds containing any of the groups the nitrogen atoms not being part of nitro or nitroso groups (9,848)
06/2005
06/16/2005WO2005037798A3 Amide or thiomide derivatives and their use in the treatment of pain
06/16/2005WO2005009943A3 Substituted tetracycline compounds
06/16/2005US20050131075 Method of preparing retroviral protease inhibitor intermediates
06/16/2005US20050131018 Acetylene derivatives as inhibitors of histone deacetylase
06/15/2005EP1539683A2 Phenol derivatives and their use as rotamase inhibitors
06/15/2005EP1305301B1 Alpha-acyl and alpha-heteroatom-substituted benzene acetamide glucokinase activators
06/15/2005CN1626510A Method for synthesizing symmetrical compound of aroma urea group
06/14/2005US6906079 Method and reagents for N-alkylating ureides
06/09/2005WO2004052845A8 Tetrahydro-naphthalene derivatives as vanilloid receptor antagonists
06/09/2005US20050124682 Such as N-{2-[5-(methylthio)-1H-indol-3-yl]ethyl}acetamide for treatment of disorders of the melatoninergic system; hormone replacement therapy
06/09/2005US20050124671 Benzylcycloalkyl amines as modulators of chemokine receptor activity
06/09/2005DE19522914B4 Thermoaufzeichnungsmaterial Thermal recording material
06/08/2005EP1537075A2 Diarylurea derivatives and their use as chloride channel blockers
06/08/2005EP1042305B1 INHIBITION OF p38 KINASE USING SYMMETRICAL AND UNSYMMETRICAL DIPHENYL UREAS
06/08/2005CN1623977A Method of preparing retroviral protease inhibitor intermediates
06/07/2005US6903128 Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases
06/02/2005WO2005028445A3 Derivatives of n-(1h-indazolyl)- and n-(1h-indolyl)-urea as well as related compounds as modulators of the vanilloid-1 receptor (vr1) for the treatment of pain
06/02/2005US20050119245 Alpha -, beta -, and gamma -amino acid derivatives, e.g., S)-2-{N'-[4-(4-Fluoro-phenoxy)-phenyl]-N''-cyano-guanidino}-3-phenyl-N-(3-pyrrolidin-1-yl-propyl)-propionamide for the treatment of central nervous system conditions such as muscle spasticity, tinnitus, epilepsy and neuropathic pain.
06/02/2005DE10348380A1 Mit sekundären Aminen blockierte Polyisocyanate mit Biuretstruktur Secondary amines were blocked polyisocyanates with biuret
06/01/2005EP1535607A1 Increased moisturization efficacy using hydroxyalkylurea
06/01/2005EP1534670A1 Enzyme activated self-immolative n-substituted nitrogen mustard prodrugs
06/01/2005EP1534669A1 Urea-, glycerate- and, hydroxyamide-headed hydrocarbon chain lyotropic phases forming surfactants
06/01/2005EP1534658A2 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
06/01/2005EP1254136A4 FACTOR Xa INHIBITORS WITH ARYL-AMIDINES AND DERIVATIVES, AND PRODRUGS THEREOF
06/01/2005EP1115695B1 (r)-chiral halogenated 1-substitutedamino-(n+1)-alkanols useful for inhibiting cholesteryl ester transfer protein activity
06/01/2005EP0993441B1 INHIBITORS OF p38
06/01/2005CN1204117C Preparation of wide compatible, stable and rheologic activating urethane solution
06/01/2005CN1204116C Process for synthesizing isoprotuion herbicide
05/2005
05/31/2005US6900213 Controlling fertility; contraceptives; anticancer agents
05/26/2005WO2005047249A1 Benzylether amine compounds useful as ccr-5 antagonists
05/26/2005US20050113580 2-(3-{3-[[2-chloro-3-(trifluoromethyl)benzyl](2,2-dephenylethyl)amino]propoxy}phenyl)-ethanol; agonists of the nuclear receptors, LXR alpha and LXR beta used to increase ABCA1, ABCG1, and apolipoprotein E expression and inhibiting cholesterol absorption
05/26/2005US20050113269 Increased moisturization efficacy using hydroxyalkylurea
05/26/2005US20050113268 Synergistic mixture of moisturizer and N-2-hydroxyethylurea; ammonium salt of lactic, glycolic, citric, maleic, acetic, and/or salicylic acid; smooth feel, flexibility, elasticity, suppleness, firmness, nongreasy
05/26/2005CA2543913A1 Benzylether amine compounds useful as ccr-5 antagonists
05/25/2005EP1532188A2 Low-cure powder coatings and methods for using the same
05/25/2005EP1532102A1 Cosmetic or dermopharmaceutical compositions comprising tyramine derivatives, method for preparing same, and use thereof
05/25/2005CN1620421A Substituted alkyl diamine
05/25/2005CN1203054C Novel benzoylurea compound and use thereof
05/24/2005US6897220 Antiproliferative agents
05/19/2005WO2005044810A1 Glyt2 modulators
05/19/2005WO2005044788A1 Urea derivative and process for producing the same
05/19/2005WO2005044787A1 Phenetanolamine derivatives
05/19/2005WO2005044786A1 Bicyclic amide, carbamate or urea derivatives as vanilloid receptor modulators
05/19/2005WO2005044007A1 Biphenyl derivative or its salt, and pesticide containing it as an active ingredient
05/19/2005WO2005015158A9 T1r hetero-oligomeric taste receptors, cell lines that express said receptors, and taste compounds
05/19/2005US20050107565 Polyisocyanates with biuret structure, blocked with secondary amines
05/19/2005CA2545100A1 Bicyclic amide, carbamate or urea derivatives as vanilloid receptor modulators
05/18/2005CN1617718A N-aryl-N'-arylcycloalkyl-urea derivatives as MCH antagonists for the treatment of obesity
05/18/2005CN1616418A Polyisocyanates with biuret structure, blocked with secondary amines
05/17/2005US6894063 Drugs for treating metabolic and eating disorders, diabetes
05/12/2005WO2005041684A2 Novel flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof
05/12/2005WO2005000803A8 Asymmetric urea compound and process for producing asymmetric compound by asymmetric conjugate addition reaction with the same as catalyst
05/12/2005US20050101644 Benzylether amine compounds useful as CCR-5 antagonists
05/12/2005CA2535036A1 Novel flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof
05/11/2005CN1615295A Compounds for treatment of inflammation, diabetes and related disorders
05/10/2005US6891072 Process for production of dimers or aromatic monohydroxyl compounds
05/06/2005WO2005040355A2 Tao kinase modulators and methods of use
05/06/2005WO2005040101A1 Acylurea connected and sulfonylurea connected hydroxamates
05/06/2005WO2005040100A1 Tetrahydro-naphthalene and urea derivatives
05/06/2005CA2543570A1 Acylurea connected and sulfonylurea connected hydroxamates
05/06/2005CA2542494A1 Tetrahydro-naphthalene and urea derivatives
05/06/2005CA2542064A1 Tao kinase modulators and methods of use
05/05/2005US20050096473 Reacting 1,1'-thiocarbonyldiimidazole with an aryl amine, e.g., benzylamine, to form 1830 thiourea (or urea)prodoucts; high speed, automatic process; anticarcinogenic agents, leukemia; enzyme inhibitors for HIV reverse transcriptase (polymerase)
05/04/2005EP0815153B1 Isocyanate compositions, method for using same, use thereof for producing coatings, and resulting coatings
05/04/2005CN1199942C Method for simultaneously modernization of ammonia producing equipment and urea producing equipment
04/2005
04/28/2005WO2005037798A2 Amide or thiomide derivatives and their use in the treatment of pain
04/28/2005WO2005007091A3 Histone deacetylase inhibitors and methods of use thereof
04/28/2005US20050090669 Aminoalcohol derivatives as beta-3 adrenergic receptor agonists
04/28/2005CA2539632A1 Amide or thioamide derivatives and their use in the treatment of pain
04/27/2005EP1525481A2 Selective binding and analysis of macromolecules: quantitative analysis of proteins in complex mixtures
04/27/2005EP1525186A1 Inhibitors of hcv ns5b polymerase
04/27/2005EP1525183A1 Inhibitors of hcv ns5b polymerase
04/27/2005CN1198797C Preparation of o-alkyl isourea
04/26/2005CA2131182C Method for making intermediates useful in synthesis of retroviral protease inhibitors
04/21/2005WO2005035471A1 Ether derivative
04/21/2005WO2004062601A3 Antibacterial agents
04/21/2005US20050084506 Amide compounds such as (R)-methyl 2-(3-chloro-4-methoxybenzamido)-4-methylpentanoate and urea compounds such as 1-(2-chlorophenyl)-3-(heptan-4-yl)urea for modulating taste of food or drug products
04/20/2005EP1524284A2 Polyisocyanates with biuretstructure blocked with secondary amines
04/20/2005EP1524281A2 Isocyanate containing compositions, process for their use, process for preparing coatings, and coatings
04/20/2005EP1524262A1 Inhibitors of histone deacetylase
04/20/2005EP1523471A1 Urea-substituted and urethane-substituted acylureas, methods for the production thereof and their use as medicaments
04/20/2005EP1307425B1 Novel n-(2-phenyl-3-aminopropyl)naphtamides
04/20/2005CN1197843C Fluorodiol and application thereof
04/17/2005CA2485156A1 Polyisocyanates with biuret structure, blocked with secondary amines
04/14/2005WO2005033230A2 Low-cure powder coatings, related coating method and coated substrates
04/14/2005US20050080271 Peptidomimetic ligands for cellular receptors and ion channels
04/14/2005US20050080121 for example, 4S-[(naphthalene-2-carbonyl)-amino]-5-(2-oxo-pyrrolidin-3S-yl)-pent-2-enoic acid ethyl ester; treatment of viral infections caused by human rhinoviruses, human polioviruses, human coxsackieviruses, human echoviruses, among others
04/13/2005EP1521739A1 Method for the continuous production of tetra-substituted ureas
04/13/2005CN1196687C Inhibitors of IMPDH enzyme
04/13/2005CN1196673C (-)-Verbenzone derivs.
04/12/2005US6878841 Diethyloctandioldicarbamates and diethyloctandioldiallophanates, method for the production and use thereof
04/12/2005US6878743 Controlling apoptosis; central nervous system disorders
04/12/2005US6878732 5,7-diazaspiro(3.4)octane and -octene derivatives; treating diseases including emesis, depression, anxiety and cough
04/07/2005WO2004103281A3 Vanilloid receptor antagonists, and methods of making and using them
04/07/2005US20050075394 Phenethanolamine derivatives for treatment of respiratory diseases
04/07/2005US20050075377 Compounds for elevating plasma lipid levels with prodrugs for humans and other mammals
04/06/2005EP1519915A2 Tricyclic steroid hormone nuclear receptor modulators
04/06/2005CN1195783C Polymerization of olefins
04/06/2005CN1195738C 2'-substd. 1, 1'-biphenyl-2-carbonamides, method for production thereof, use thereof as medicament and pharmaceutical preparation contg. said compounds
04/05/2005US6875884 Urea derivatives as inhibitors for CCR-3 receptor
1 ... 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 ... 99